Entrada Therapeutics(TRDA) - 2024 Q4 - Annual Results

Exhibit 99.1 2025 J.P. Morgan Healthcare Conference NASDAQ: TRDA Disclaimer This presentation has been prepared by Entrada Therapeutics. Inc. (the "Corpany") and shall not constitute an offer to sell or a solicitation ol or inducement to engage in investment activity nor shall there be any sale of securities in any juisdiction in which such offer, solicitation or sa or qualification of such securities under the securities law of any such jurisdiction. The Company has filed a shelf registration statement (in ...